Dr. Muhammad Chaudhry of Aultman Hospital, Ohio, presents an emergent high-risk PCI case involving a 95% left main blockage along with a 80-90% blockage in the RCA and 100% distal RCA occlusion. The patient began experiencing severe chest pain and was evaluated for surgery. Shortly after, the patient went into asystole and CPR was initiated. … Continue reading “High-Risk PCI with Impella 2.5”
Category: Protected PCI
Dr. Siby Ayalloore presents a compelling case of decision-making for a very functional 90 year old patient with left main disease including mid-LAD disease and proximal circ disease. As a heart failure physician, he collaborated with surgeons and interventionalists. This heart team approach led to the decision to perform a successful high-risk PCI. Tweet this, … Continue reading “Difficult Decisions: Case Review with Dr. Siby Ayalloore, of Cardiovascular Institute of the South”
Dr. Aaron Grantham of St. Luke’s Mid-American Heart Institute presents how to measure the added value of high-risk PCI by first understanding the underlying economics. Given the cost cutting nature of hospital administrators, health care providers must know the data that determine costs and develop a programmatic approach to measuring value. Tweet this, subscribe or join … Continue reading “Managing the Economics of CHIP and Making the Case for Added Value”
Dr. Sukhdeep Basra presents a high-risk PCI case with one of the highest degrees of surgical inoperability possible. In this award-winning case review initially presented at TCT, Dr. Basra credits intensive planning and the Impella® for the patient’s successful release POD 5. Subscribe, or join the conversation by following us on Twitter: @ProtectedPCI ICP-020-17
New Study Finds Impella® Heart Pump Reduces Injury to Kidneys During High-Risk Percutaneous Coronary Intervention
Specialist Opinion with Dr. Seth Bilazarian A new retrospective, single-center study published in Circulation Research finds use of hemodynamic support with Impella 2.5® heart pump during high-risk percutaneous coronary intervention (HRPCI) can reduce the risk of acute kidney injury (AKI) even when those patients had preexisting kidney disease and low ejection fraction (EF). The new … Continue reading “New Study Finds Impella® Heart Pump Reduces Injury to Kidneys During High-Risk Percutaneous Coronary Intervention”
Vanderbilt Heart and Vascular Institute’s Dr. Elias Haddad shares a Protected PCI case of a 70 year, old heavy smoker presenting with what was believed to be bronchitis. After multiple misdiagnoses, the heart team approach reveals Systolic Heart Failure with an EF of 15%. This multidisciplinary approach and Impella support allowed for complete revascularization. Tweet … Continue reading “Heart Team Approach for Problem-Solving Addressed a Complex PCI”
University of Washington’s Dr. Mark Reisman describes how to develop a CHIP Protected PCI program. In this comprehensive presentation, Dr. Reisman details out the proper steps which include building a multidisciplinary heart team and fostering a CHIP alliance with other hospitals. Tweet this, subscribe or find an Impella training course near you.
Drs. John Lasala, Bill O’Neill, Jeff Moses, and Bill Lombardi explain the benefit of Impella support during Protected PCI for revascularization.Impella 2.5 and Impella CP are now approved by the FDA as safe and effective for use during high-risk PCI procedures. Learn more about the data and the clinical guidelines that support the approval. Additionally, learn how to identify patients who can benefit from Protected PCI and revascularization. Tune into this valuable conversation! Chapters include:
- Maintaining Hemodynamic stability during high-risk PCI
- Complete Revascularization is the Therapeutic Goal
- Clinical Outcomes with PCI
Dr. Perwaiz Meraj of North Shore University Hospital in Long Island shares his Protected PCI program experiences. He also provides tips and insight on how to get Impella® for Protected PCI and other indications widely adopted in your hospital. Tweet this, subscribe or find educational opportunities near you.
More than 15 million Americans suffer from coronary artery disease (CAD), the leading cause of mortality in the United States. According to the online journal Circulation, CAD patients who fail to modify their lifestyle and/or present poor adherence to a medication regimen aimed to control CAD risk factors often place themselves at higher risk for … Continue reading “The Evolving Landscape of CAD Treatment for Patients with an Indication for Revascularization”